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Abstract
Objectives: The current objective was to compare Hispanic mortality rates to those of other

racial/ethnic groups in order to investigate the possibility of a Hispanic mortality advantage.
Methods: We conducted a systematic review and meta-analysis of the published longitudinal

literature reporting Hispanic individuals’ mortality of any cause compared with that of any other
racial/ethnic group.
Results: Across 58 studies (4,615,747 participants), the random effects weighted average effect

size was OR = 0.825 (P < .001, 95% CI = 0.75 to 0.91), corresponding to a 17.5% lower risk of
mortality among Hispanic populations compared to other racial groups. The difference in
mortality risk tended to be greater among older populations and varied as a function of preexisting health condition, with effects apparent for initially healthy samples and for those with
cardiovascular diseases. The results also differed by racial group comparison: Hispanics had
lower overall risk for mortality than non-Hispanic Whites and non-Hispanic Blacks, but overall
higher risk for mortality than Asian Americans.
Conclusions: These findings provide evidence of a small Hispanic mortality advantage, with

implications for conceptualizing and addressing racial/ethnic health disparities.
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INTRODUCTION
Despite a significantly worse risk factor profile, Hispanics in the U.S. often experience
similar or better health outcomes across a range of health and disease contexts compared to nonHispanic Whites (NHW), an epidemiological phenomenon commonly referred to as the
“Hispanic Paradox”. Amongst the most salient features of this advantage is evidence that
Hispanics appear to live longer than NHW.1-3 These findings are largely based on national cohort
data, with mortality data from the US Vital Statistics System used in the numerator and
population counts from the US Census used in the denominator, yielding a death rate statistic.
The classic explanations for these paradoxical findings suggest that either the denominator is
artificially low due to Hispanics returning to their countries of origin prior to death (i.e., the
“Salmon bias hypotheses”) or that the numerator is not representative due to the healthiest
Hispanics migrating to the U.S. (i.e., the “Healthy migrant hypothesis”) have been largely
refuted.4 The contemporary overarching concern is that the statistical estimation approach
remains flawed due to underreporting of ethnicity on death certificates. Despite recent data
suggesting that the associated error is negligible,5-6 the validity of the paradox remains in
question due to its strong ties to this methodology.
One solution to these issues is to examine longitudinal studies in which race and ethnicity
are assessed at study entry and participants are followed longitudinally to mortality. This
literature has added a wealth of data for and against a Hispanic mortality advantage, but has
failed to clarify the overall relationship. A number of factors impede consensus, including
differences in sample size, selection criteria, methodologies, follow-up time, statistical reporting,
and outcomes (i.e., morbidity, specific-cause mortality, all-cause mortality). In addition, at least
five narrative literature reviews of the associated data7-11 were published in the last decade
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asserting the level of interest but failing to provide an empirical test (e.g., meta-analysis) to
clarify the discrepancy. Hence, the current status of the Hispanic Mortality Paradox can best be
described as one of great interest with significant logistical confusion.
The current objective was to systematically review the longitudinal literature comparing
Hispanic mortality rates to those of other racial/ethnic groups and to conduct a meta-analysis of
the available data as a definitive test of whether there is a relative Hispanic mortality advantage.
Resolving the validity of the phenomenon will facilitate future research efforts to identify
contributing resilience factors which may lead to targeted interventions. In the present study we
focused on all-cause mortality (death from any cause) as the primary dependent variable and
evaluated mortality within specific disease contexts to the extent that sufficient data were
available. We improve on prior reviews by using meta-analytic procedures that take into account
the differences in available studies regarding sample size, participant characteristics, selection
criteria, and methodology.

METHODS
Ethics Statement
Following consultation with our respective Institutional Review Boards, approval was not
sought given the nature of the study and its use of published, de-identified data.
Identification of Studies
Studies were identified through two techniques. First, we conducted extensive electronic
database searches for the time frame of January 1990 to July 2010, using Medline, PubMed,
EMBASE, HealthSTAR, and PsycINFO. January 1990 was used as the beginning search date
due to methodological changes in the use of the terms such as Hispanic in race and ethnicity data
collection and publication efforts.12-13 To capture the broadest possible sample of relevant
Hispanic Paradox
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articles, three search term categories were used: (1) Hispanic (Hispanic, Latino, Mexican, Puerto
Rican, Cuban); (2) Mortality (mortality, death, longevity, survival, lifespan); (3) Design
(prospective, longitudinal). Second, we manually examined the reference sections of past
reviews and of studies meeting the inclusion criteria to locate articles not identified in the
database searches.
Inclusion Criteria
In the meta-analysis we included only published studies meeting the following criteria:
(1) written in English or Spanish, (2) used a longitudinal design; and (3) provided quantitative
data regarding Hispanic individuals’ mortality compared with that of other racial/ethnic groups.
We excluded studies in which the outcome was not explicitly stated as mortality (e.g.,
combined outcomes of morbidity/mortality), studies of infant mortality, single-case designs, and
reports with exclusively aggregated data (e.g., census-level statistics). We included all other
types of quantitative research designs that were longitudinal and yielded a statistical estimate of
the risk of mortality among Hispanic populations compared to that of other racial/ethnic groups.
There were no age limitations other than those related to studies of infant mortality. However,
the published literature on mortality is largely skewed towards higher ages as reflected here.
Data Abstraction
Articles were independently coded by two teams with two members each. A third
independent member then compared the two ratings, resolving discrepancies through joint
review with the teams. Coders extracted several objectively verifiable characteristics of the
studies: (1) the number of participants and their composition by age, ethnicity, gender, and preexisting health conditions (if any), as well as the cause of mortality; (2) length of follow up; and
(3) research design. Given the substantial heterogeneity amongst Hispanic peoples exemplified
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by differences in culture, traditions, and importantly, health outcomes, we further sought to code
by country of origin/nativity when such data were available. Although we intended to include
data regarding participant acculturation/enculturation, no studies reported information regarding
participants’ immigration status or years living in the U.S., two studies reported information
regarding percentage of foreign-born participants, and only ten studies reported participant
average level of education, so our analyses could not include those variables.
Data within studies were often reported in terms of odds ratios (OR), the likelihood of
mortality contrasted by ethnic group. Because OR values cannot be meaningfully aggregated, all
effect sizes reported within studies were transformed to the natural log OR (lnOR) for analyses
and then transformed back to OR for interpretation. When effect size data were reported in any
metric other than OR or lnOR, we transformed those values using statistical software programs
and macros (e.g., Comprehensive Meta-Analysis14). In many cases we calculated effect sizes
from frequency data in matrices of mortality status by ethnicity. In cases when frequency data
were not reported, we recovered the cell probabilities from the reported risk ratio and marginal
probabilities. Across studies we assigned OR values less than1.00 to data indicative of decreased
mortality among Hispanics and OR values greater than 1.00 to data indicative of increased
mortality among Hispanics relative to the comparison group(s).
When multiple effect sizes were reported within a study at the same time, we averaged
the values (weighted by standard error) to avoid violating the assumption of independent
samples. When a study contained multiple effect sizes across time, we extracted the data from
the longest follow-up period. If a study used statistical controls in calculating an effect size, we
extracted the data from the model utilizing the fewest statistical controls. We coded the research
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design used rather than estimate risk of individual study bias. The coding protocol is available
from the authors.
Information obtained from the studies was extracted directly from the reports. As a result,
the inter-rater agreement was high for categorical variables (mean Cohen’s kappa = 0.97, SD =
0.02) and for continuous variables (mean intraclass correlation = 0.93, SD =0.14). Discrepancies
across coders were resolved through further scrutiny of the manuscript until consensus was
obtained.
Aggregate effect sizes were calculated using random effects models following
confirmation of heterogeneity. A random effects approach yields results that generalize beyond
the sample of studies actually reviewed.15 We assumed that the results would differ as a function
of participant characteristics (i.e., age, gender) and study design (i.e., length of follow-up).
Random effects models take this between-studies variation into account, whereas fixed effects
models do not.16

RESULTS
Literature Search and Study Characteristics
Figure 1 shows the study selection process. Statistically non-redundant effect sizes were
extracted from 58 studies17-74 (see Table 1). Data were reported from 4,615,747 total participants,
with an average composition of 26% Hispanic participants within studies. The average ages of
participants at initial evaluation were 54.6 years (SD = 11.6) for Hispanics and 56.1 years (SD =
11.7) for comparison groups. Hispanic participants consisted of 44% women, and comparison
groups included 45% women. Research reports typically failed to describe the specific ethnic
heritage of the Hispanic participants (80% omitting this information), but eight studies (15%)
were specific to Mexican Americans,20, 29, 33, 42, 47, 52, 67, 72 one study was specific to Puerto Rican
Hispanic Paradox
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Americans48, and five studies (9%) involved participants from a variety of ethnic backgrounds.2425, 31, 36, 51

Several studies (22%) involved initially healthy participants, but 24% of studies

involved patients with cardiovascular disease (CVD), 12% with cancer, 10% with HIV infection,
7% with diabetes, 5% with renal disease, and the remaining 20% with a variety of conditions
including liver disease and dementia. Research reports most often (91%) considered all-cause
mortality, but some restricted evaluations to mortality associated with CVD (5%) or other
specific causes (4%). Only eight studies (14%) involved a medical intervention;21, 24-25, 33, 35, 45, 62,
73

most merely tracked participants’ mortality over time. Participants were followed for an

average of 6.9 years (SD = 5.9, range = 1 month to 33 years). Note that PRISMA and MOOSE
guidelines were adhered to in the design and reporting of this study.75-76
Omnibus Analysis
Across the 58 studies, the random effects weighted average effect size was OR = 0.825
(P< .0001, 95% Confidence interval = 0.75 to 0.91). As shown in Figure 2, odds ratios ranged
from 0.39 to 2.75, with an extremelylarge degree of heterogeneity across studies (I2 = 96%; Q(57)
= 1564, p< .001;  = .12), suggesting that systematic effect size variability was unaccounted for.
Thus it was likely that factors associated with the studies themselves (e.g., publication status),
participant characteristics (e.g., age, health status), and/or the research design (e.g., length of
follow-up) may have moderated the overall results. We therefore conducted additional analyses
to determine the extent to which the variability in the effect sizes was moderated by these
variables.
Evaluation for Publication Bias
To assess the possibility of publication bias77, we conducted four analyses. First, we
calculated Orwin’s fail-safe N,78 the theoretical number of unpublished studies with effect sizes

Hispanic Paradox

Page 9
averaging zero (no effect) that would need to be located in order to reduce the overall magnitude
of the results obtained to a trivial estimate of 1.0 > OR > 0.95. Based on this calculation, at least
367 additional studies averaging OR = 1.0 would need to be found to render negligible the
results of the present meta-analysis. Second, we utilized both Egger’s regression test79 and the
alternative to that test recommended by Peters and colleagues80 that is better suited to data in OR
format. The results of these two analyses failed to reach statistical significance (P > .05). Third,
we generated a “funnel plot”81 of the studies’ log odds ratios by the standard errors. The data
obtained from this meta-analysis were not symmetrically distributed around the grand mean;
there appeared to be multiple studies “missing” from the bottom left corner of the distribution.
However, these studies were in the opposite corner from what would have been expected.
Typically, “missing” studies are in the region of non-significance if publication bias is present. In
this case, the data underrepresented studies with relatively fewer participants that demonstrated
lower mortality rates among Hispanics. Finally, we employed the “trim and fill” methodology
described by Duval and Tweedie.82-83 This analysis indicated that when 14 estimated “missing”
studies were included in the analysis, the overall effect size was calculated to be OR = 0.70 (95%
CI = 0.64 to 0.77), indicating that Hispanic participants were 30% less likely to die than
comparison group members over the same period of time. Based on these four analyses, we
concluded that the data do not reflect publication bias per se, but that they may represent a
conservative estimate of risk for mortality among Hispanic populations.
Moderation by Participant and Study Characteristics
To investigate whether the lower risk of mortality among Hispanic populations varied as
a function of participant characteristics within studies, we conducted analyses involving
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participants’ age, gender, and pre-existing diagnoses. We also investigated any differences across
studies due to length of follow-up, type of research design, and cause of mortality.
To establish whether the average age of the sample accounted for significant betweenstudies variance, the effect sizes from the 53 studies that reported participants’ average age at
intake were correlated with the corresponding effect size for that study. The resulting random
effects weighted correlation was -.28 (P = .03), indicating that studies with older populations
tended to demonstrate lower risk of mortality among Hispanic participants relative to comparison
groups. As a first step to verify that this association was specific to chronological age, we
investigated the possible confounding association with trends over time (i.e., age cohort).
However, when we correlated the effect sizes with a variable created by subtracting the average
age of participants at the start of the study from the year of initial data collection (an estimate of
the average year of participant birth), the resulting value of r = .22 did not reach statistical
significance (P = .10). Because older populations are more likely to receive treatment than
younger populations, we conducted a second analysis to verify the association observed with
participant age by simultaneously regressing participant age and the type of research study
(intervention vs. observation) on study effect size. In this model, the average age of participants
remained statistically significant (b = -.28, P = .04), but the type of research study (intervention
vs. observation) did not. The differences observed in risk for mortality appear to be moderated
by participant age.
Similar random effects weighted correlations with the gender composition of each sample
(using percent female; r = -.23) and the length of time participants were followed (r = .07) did
not reach statistical significance (P > .05). Furthermore, no differences in the average effect sizes
were found between studies using prospective vs. retrospective designs (Q1,57 = 0.1, P > .05).
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Studies evaluating all-cause mortality had effect sizes of equivalent magnitude to those from the
studies in which a specific cause of death was evaluated (i.e., cancer; Q = 0.3; P > .05). Thus the
omnibus results presented earlier were not moderated by these variables.
As can be seen in Table 2, statistically significant differences were found across
participants’ type of health condition at the point of initial evaluation (Q =11.5; P = .02).
Community samples of Hispanics with no identified health impairment had the greatest mortality
advantage (estimated 30%) relative to non-Hispanics. Hispanic ethnicity was also associated
with a 25% reduced mortality advantage among individuals with CVD and an estimated 16%
advantage among persons with a variety of other pre-existing health conditions. However,
Hispanics diagnosed with HIV/AIDS or cancer had a risk of mortality that did not significantly
differ from non-Hispanics.
Because studies compared Hispanic participants with different ethnic groups, we
conducted a random effects weighted analysis of variance across the several comparisons
conducted within studies (such that each study contributed as many effect sizes as it had unique
comparisons with different ethnic groups84). As shown in Table 3, there was a significant
difference across ethnicity (Q =6.5; P < .05). Hispanic participants were less likely to die over
time when compared with both NHWs and non-Hispanic Blacks (NHB), but they were more
likely to die than Asian Americans during the same follow-up period.

DISCUSSION
Results of this meta-analysis show that Hispanic ethnicity is associated with a 17.5%
lower likelihood of mortalityrelative to non-Hispanics, which figure is comparable to the 20%
advantage reported by Arias and colleagues5 using the alternative death statistic estimation
strategy. The omnibus finding in the current study is moderated by age such that the effect
Hispanic Paradox
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becomes stronger among older participants, a finding similar to that which was recently reported
using the estimation approach.85 In addition, the Hispanic mortality advantage varied as a
function of pre-existing health status at study entry. Specifically, Hispanics displayed a
significant mortality advantage among studies of initially healthy samples as well as in the
context of cardiovascular disease and other health conditions, such as renal disease. With respect
to studies of persons with cancer and HIV/AIDS, Hispanics and non-Hispanics experienced
equivalent mortality risk. Findings also indicated that although Hispanics had a significant
overall mortality advantage relative to NHWs and NHBs they were marginally disadvantaged
relative to Asian Americans.
When considered along with the consistent state and national vital statistics evidence
including the recent CDC report clearly stating a Hispanic ethnicity mortality advantage,3 it may
be time to move beyond the question of the existence of the Hispanic Mortality Paradox and onto
investigations into the causes of such resilience. An important conceptual consideration is that
the observed mortality advantage, as well as the broader health outcome advantages evident in
the Hispanic Paradox, may be due to resilience at several points in the course of disease.
Hispanics may be less susceptible than some other races to illness in general or to specific
conditions with high mortality rates, such as cardiovascular disease. It is also possible that the
rate of disease progression may be slower among Hispanics, resulting in lower morbidity and
greater longevity. Finally, the mortality advantage may reflect an advantage in survival and
recovery from acute clinical events (e.g., MI, stroke). Hence further research is needed to
ascertain whether the observed Hispanic mortality advantage reflects advantages at specific
points in the disease course and whether such time-point differences vary by disease context.
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Several risk and resilience factors may contribute to these effects including potential
biological (e.g., genetics, immune functioning), behavioral (e.g., diet, smoking), psychological
(e.g., stress, personality), and social (e.g., acculturation, social cohesion) differences86. Although
not assessed in the current study, lower SES is a robust predictor of worse health outcomes.87
However, the current findings challenge the generalizability of this relationship given the
typically lower SES of Hispanics relative to NHWs. It’s possible that SES either does not
contribute to risk among Hispanics or confers risk only as moderated by some third variable. For
example, emerging data suggest that acculturation moderates the relationship between SES and
disease risk among Hispanics such that there is a buffering effect of SES associated with low
levels of acculturation and a more traditional SES gradient effect at higher acculturation levels.88
Acculturation may be a proxy for social behaviors and cultural values which buffer against the
stress of economic and environmental disadvantages. It is also possible that the relative impact of
traditional risk factors such as diabetes and lipids differ by ethnicity and contribute to the
observed paradox. More research is needed to identify risk and resilience mechanisms as well as
understand potentially complex interaction patterns which may explain the observed effects.
The current study is a reminder to physicians and researchers about the heterogeneity in
racial/ethnic minority health. Despite similar risk factor profiles, Hispanics had significantly
lower all-cause mortality relative to NHBs. Such findings support a need for Hispanic-specific
comparative research to determine where such differences occur in specific disease courses and
outcomes as well as to investigate potential racial and ethnic differences in the relative weight or
influence of identified risk factors for disease. Given evidence of Hispanic heterogeneity in
health outcomes, subgroup comparative research is also warranted.
Limitations
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We cannot entirely rule out the possibility of selection bias as an alternative explanation
for the findings. Although we made significant efforts to identify all relevant published studies,
and data checks indicated no significant violations of publication distribution, our results may yet
reflect some degree of bias. For example, limiting inclusion to only those studies in English or
Spanish may result in a language bias. The number of available studies also limited our ability to
examine mortality in specific contexts including diabetes, autoimmune conditions, injury,
neurological disorders, and others as well as test effects of acculturation or generational status.
We were also unable to address questions regarding whether the observed effect has been
constant or is decreasing over time. Study availability may also have limited our ability to detect
subtle effects, as in the context of cancer and HIV where observed effects may have been
significant with a larger number of studies. Lack of reporting also limited our ability to examine
several key moderators including SES and health behaviors which are shown to influence
outcomes.89 To these points we would note that we did not examine unpublished manuscripts
which could also affect findings. Finally, the analyzed sample was predominantly Mexican
American, which likely limits generalizability across Hispanic subgroups, particularly given
evidence of significant heterogeneity in Hispanic subgroup mortality outcomes.90-91
Conclusions
These findings should serve as a cornerstone to documenting a comparative Hispanic mortality
advantage in the context of a disadvantaged risk factor profile and demonstrate important heterogeneity
in racial/ethnic minority health. Further, these findings highlight the need for specific comparative studies
involving Hispanics as opposed to generalizing findings of Black-White differences. A next challenge is to
identify factors that promote resilience across the lifespan, and in turn, have the potential for informing
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Table 1. Characteristics of Included Studies
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Havranek et al, 200838
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Jokela et al, 200941
Lee et al, 199042
Liao et al, 199943
Lin et al, 200344
Mak et al, 200945
Manoharan et al, 200846
Medina et al, 199647
Mendenhall et al, 198948
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Total N
90,316
250
1,027
327
2,486
281
15,610
27,788
22,576
692,574
200
7,007
107
25,568
396
7,723
15,329
41,901
1,028
980
1,238,317
7,495
323
71,798
8,544
446
696,697
553,307
15,376
400
584
428

Hispanic
N
9,835
71
31
125
92
100
2,600
734
8,045
9,868
36
344
64
3628
220
994
970
2,061
358
483
311,082
1,789
179
41,665
1736
312
52,725
33,954
1,613
67
236
63

%
Hispanic
11
28
3
38
4
36
17
3
36
1
18
5
60
14
56
13
6
5
35
41
25
24
55
58
20
70
8
6
10
17
40
15

%
Women
55
87
35
38
40
19
17
26
61
NA
5
38
73
44
86
46
55
50
50
50
0
49
70
52
50
61
53
54
34
33
60
0

Mean
Age
Sample
69
47
35
37
65
59
36
59
66
>65
38
63
62
72
35
59
44
>65
7
66
28
56
87
63
20
>60
38
>25
64
67
62
49

Follow-Up
(Years)
1
6
<1
5
5
3
3
<1
3
1
6
1
7
5
10
1
12
7
4
5
5
<1
4
6
25
8
9
11
3
14
4
5

Health Status at
Study Entry
CVD
Scleroderma
Respiratory failure
HIV/AIDS
CVD
Cancer
HIV/AIDS
CVD
CVD
CVD
HIV/AIDS
CVD
Stroke
Extremity bypass
Autoimmune
Kidney Disease
Cancer
Cancer
HIV/AIDS
Stroke
None apparent
CVD
Dementia
None apparent
None apparent
None apparent
None apparent
None apparent
CVD
Cancer
Diabetes
Liver Disease

Analysis
Category
CVD
Other
Other
HIV/AIDS
CVD
Cancer
HIV/AIDS
CVD
CVD
CVD
HIV/AIDS
CVD
Other
Other
Other
Other
Cancer
Cancer
HIV/AIDS
Other
None/Community
CVD
Other
None/Community
None/Community
None/Community
None/Community
None/Community
CVD
Cancer
Other
Other
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Murthy et al, 200549
100,618
10,393
10
Ostir et al, 200650
506
153
30
Palmas et al, 200951
1,178
451
38
Patel et al, 200452
66,397
1,114
2
Peralta et al, 200653
39,550
12,076
31
Perez E et al, 200754
312
91
29
Perez M et al, 200755
44,171
2,625
6
Plurad et al, 201056
3,998
2,495
62
Robinson et al, 200657
6,677
673
10
Sacco et al, 199158
394
82
21
Sacco et al, 200959
2,670
1,443
54
Schupf et al, 200560
2,247
876
39
Segev et al, 201061
79,034
9,846
12
Serna et al, 200362
5,122
413
8
Shaw et al, 200863
346,075
7,823
2
Silverberg et al, 200964
4,787
661
14
Smyth et al, 200765
581
323
56
Stefanidis et al, 200666
408
296
73
Steffen-Batey et al, 200067
406
196
48
Sudano et al, 200668
8,400
723
9
Swenson et al, 200269
1,862
921
49
Tedaldi et al, 200870
1,301
225
17
Waring et al, 200571
956
37
4
Wei et al, 199672
3,735
2,630
70
Wolf et al, 200873
9,303
979
11
Young et al, 200374
337,870
26,544
8
Abbreviations: CVD, Cardiovascular disease; NA, not available.
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47
51
55
56
59
46
9
18
45
51
63
66
59
41
47
10
0
44
41
52
57
20
73
59
44
1

59
81
72
73
62
58
54
33
57
63
66
76
39
NA
61
37
25
54
59
56
52
38
72
43
61
64

2
5
7
8
4
20
8
7
5
1
9
3
6
5
<1
9
33
16
7
6
11
5
13
8
1
2

Kidney disease
None apparent
Diabetes
None apparent
Kidney disease
Cancer
CVD
Sepsis
Kidney Disease
Stroke
None apparent
None apparent
None apparent
Cancer
CVD
HIV/AIDS
Heroin addiction
Cancer
CVD
None apparent
Diabetes
HIV/AIDS
Dementia
None apparent
Kidney Disease
Diabetes

Other
None/Community
Other
None/Community
Other
Cancer
CVD
Other
Other
Other
None/Community
None/Community
None/Community
Cancer
CVD
HIV/AIDS
Other
Cancer
CVD
None/Community
Other
HIV/AIDS
Other
None/Community
Other
Other
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Table 2. Analyses of Weighted Average Effect Sizes across Type of Pre-existing
Health Condition
Variable

Qb

Type of Health Condition
11.5
None apparent (community samples)
Cardiovascular disease
Cancer
HIV/AIDS
Other conditions

p

k

OR

95 % CI

13
11
7
6
21

0.70
0.75
1.21
0.86
0.84

[0.58, 0.85]
[0.61, 0.91]
[0.92, 1.59]
[0.64, 1.17]
[0.72, 0.99]

.02

Note. k = number of studies. OR = odds ratio, transformed from random effects weighted
lnOR. Qb = Q-value for variance between groups.
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Table 3. Odds of Survival by Race (Compared with Hispanics).
Qb

p

k

OR

95 % CI

Race
6.5
.04
Asian
9
1.19
[0.90, 1.56]
Non-Hispanic Black
40
0.87
[0.76, 0.99]
Non-Hispanic Whites
53
0.81
[0.73, 0.91]
Note. k = number of studies. OR = odds ratio, transformed from random effects weighted
lnOR. Qb = Q-value for variance between groups.
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Figure Legend
Figure 1. Selection of Articles for Meta-Analysis
Figure 2. Meta-Analysis of Hispanic Ethnicity and All-Cause Mortality
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